BCRX logo

BioCryst Pharmaceuticals (BCRX) Long term liabilities

Annual long term liabilities:

$805.97M-$16.53M(-2.01%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BCRX annual total long term liabilities is $805.97 million, with the most recent change of -$16.53 million (-2.01%) on December 31, 2024.
  • During the last 3 years, BCRX annual long term liabilities has risen by +$214.55 million (+36.28%).
  • BCRX annual long term liabilities is now -2.01% below its all-time high of $822.50 million, reached on December 31, 2023.

Performance

BCRX Long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXbalance sheet metrics

quarterly long term liabilities:

$792.12M-$13.85M(-1.72%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BCRX quarterly total long term liabilities is $792.12 million, with the most recent change of -$13.85 million (-1.72%) on March 31, 2025.
  • Over the past year, BCRX quarterly long term liabilities has dropped by -$32.02 million (-3.89%).
  • BCRX quarterly long term liabilities is now -6.05% below its all-time high of $843.15 million, reached on September 30, 2023.

Performance

BCRX quarterly long term liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBCRXbalance sheet metrics

Long term liabilities Formula

Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities

BCRX Long term liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-2.0%-3.9%
3 y3 years+36.3%+29.7%
5 y5 years+1703.3%+1868.4%

BCRX Long term liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-2.0%+36.3%-6.0%+29.7%
5 y5-year-2.0%+1703.3%-6.0%+2470.8%
alltimeall time-2.0%>+9999.0%-6.0%>+9999.0%

BCRX Long term liabilities History

DateAnnualQuarterly
Mar 2025
-
$792.12M(-1.7%)
Dec 2024
$805.97M(-2.0%)
$805.97M(-0.0%)
Sep 2024
-
$806.25M(-1.6%)
Jun 2024
-
$818.96M(-0.6%)
Mar 2024
-
$824.14M(+0.2%)
Dec 2023
$822.50M(+11.3%)
$822.50M(-2.4%)
Sep 2023
-
$843.15M(+2.2%)
Jun 2023
-
$825.10M(+9.6%)
Mar 2023
-
$752.87M(+1.9%)
Dec 2022
$739.08M(+25.0%)
$739.08M(+2.7%)
Sep 2022
-
$719.62M(+14.5%)
Jun 2022
-
$628.38M(+2.9%)
Mar 2022
-
$610.92M(+3.3%)
Dec 2021
$591.42M(+138.2%)
$591.42M(+111.8%)
Sep 2021
-
$279.20M(+4.3%)
Jun 2021
-
$267.76M(+3.7%)
Mar 2021
-
$258.22M(+4.0%)
Dec 2020
$248.32M(+455.6%)
$248.32M(+705.9%)
Sep 2020
-
$30.81M(-13.3%)
Jun 2020
-
$35.55M(-11.7%)
Mar 2020
-
$40.24M(-10.0%)
Dec 2019
$44.70M(+58.9%)
$44.70M(-9.9%)
Sep 2019
-
$49.58M(-7.5%)
Jun 2019
-
$53.59M(+0.2%)
Mar 2019
-
$53.51M(+90.2%)
Dec 2018
$28.13M(+43.1%)
$28.13M(-9.5%)
Sep 2018
-
$31.08M(+90.8%)
Jun 2018
-
$16.29M(-9.4%)
Mar 2018
-
$17.98M(-8.5%)
Dec 2017
$19.66M(-42.0%)
$19.66M(-9.1%)
Sep 2017
-
$21.62M(-29.1%)
Jun 2017
-
$30.50M(-6.0%)
Mar 2017
-
$32.43M(-4.4%)
Dec 2016
$33.91M(+173.9%)
$33.91M(-5.8%)
Sep 2016
-
$35.99M(+184.8%)
Jun 2016
-
$12.64M(+5.2%)
Mar 2016
-
$12.01M(-2.9%)
Dec 2015
$12.38M(+213.7%)
$12.38M(+18.3%)
Sep 2015
-
$10.47M(+1.4%)
Jun 2015
-
$10.32M(+184.0%)
Mar 2015
-
$3.63M(-7.9%)
Dec 2014
$3.95M(-88.6%)
$3.95M(+2.5%)
Sep 2014
-
$3.85M(-44.6%)
Jun 2014
-
$6.95M(-80.4%)
Mar 2014
-
$35.42M(+2.0%)
Dec 2013
$34.74M(-14.6%)
$34.74M(-5.1%)
Sep 2013
-
$36.61M(-1.1%)
Jun 2013
-
$37.01M(-3.7%)
Mar 2013
-
$38.41M(-5.5%)
Dec 2012
$40.67M(-1.1%)
$40.67M(-2.6%)
Sep 2012
-
$41.75M(+0.7%)
Jun 2012
-
$41.47M(+1.7%)
Mar 2012
-
$40.77M(-0.8%)
Dec 2011
$41.10M(+157.8%)
$41.10M(-12.8%)
Sep 2011
-
$47.14M(-0.1%)
Jun 2011
-
$47.19M(+0.8%)
Mar 2011
-
$46.83M(+193.7%)
Dec 2010
$15.94M(-14.6%)
$15.94M(-4.9%)
Sep 2010
-
$16.76M(-3.7%)
Jun 2010
-
$17.40M(-3.5%)
Mar 2010
-
$18.03M(-3.4%)
Dec 2009
$18.67M
$18.67M(-3.3%)
DateAnnualQuarterly
Sep 2009
-
$19.31M(-3.2%)
Jun 2009
-
$19.95M(-2.8%)
Mar 2009
-
$20.52M(-3.0%)
Dec 2008
$21.16M(-57.4%)
$21.16M(-54.8%)
Sep 2008
-
$46.78M(-2.3%)
Jun 2008
-
$47.88M(-2.2%)
Mar 2008
-
$48.98M(-1.4%)
Dec 2007
$49.69M(+35.8%)
$49.69M(-2.2%)
Sep 2007
-
$50.81M(-2.1%)
Jun 2007
-
$51.93M(+28.7%)
Mar 2007
-
$40.34M(+10.2%)
Dec 2006
$36.60M(+24.4%)
$36.60M(-1.8%)
Sep 2006
-
$37.27M(-1.4%)
Jun 2006
-
$37.80M(-0.5%)
Mar 2006
-
$38.00M(+29.1%)
Dec 2005
$29.43M(+9708.7%)
$29.43M(+9708.7%)
Sep 2005
-
$300.00K(0.0%)
Jun 2005
-
$300.00K(0.0%)
Mar 2005
-
$300.00K(0.0%)
Dec 2004
$300.00K(0.0%)
$300.00K(0.0%)
Sep 2004
-
$300.00K(0.0%)
Jun 2004
-
$300.00K(0.0%)
Mar 2004
-
$300.00K(0.0%)
Dec 2003
$300.00K(0.0%)
$300.00K(0.0%)
Sep 2003
-
$300.00K(0.0%)
Jun 2003
-
$300.00K(0.0%)
Mar 2003
-
$300.00K(0.0%)
Dec 2002
$300.00K(0.0%)
$300.00K(0.0%)
Sep 2002
-
$300.00K(0.0%)
Jun 2002
-
$300.00K(0.0%)
Mar 2002
-
$300.00K(0.0%)
Dec 2001
$300.00K(-94.3%)
$300.00K(0.0%)
Sep 2001
-
$300.00K(0.0%)
Jun 2001
-
$300.00K(-93.4%)
Mar 2001
-
$4.52M(-13.4%)
Dec 2000
$5.22M(+1641.2%)
$5.22M(+1641.2%)
Sep 2000
-
$300.00K(0.0%)
Jun 2000
-
$300.00K(-0.9%)
Mar 2000
-
$302.70K(+0.9%)
Dec 1999
$300.00K(0.0%)
$300.00K(0.0%)
Sep 1999
-
$300.00K(0.0%)
Jun 1999
-
$300.00K(-25.0%)
Mar 1999
-
$400.00K(+33.3%)
Dec 1998
$300.00K(0.0%)
$300.00K(0.0%)
Sep 1998
-
$300.00K(-25.0%)
Jun 1998
-
$400.00K(+33.3%)
Mar 1998
-
$300.00K(0.0%)
Dec 1997
$300.00K(0.0%)
$300.00K(-25.0%)
Sep 1997
-
$400.00K(0.0%)
Jun 1997
-
$400.00K(0.0%)
Mar 1997
-
$400.00K(+33.3%)
Dec 1996
$300.00K(-57.1%)
$300.00K(-25.0%)
Sep 1996
-
$400.00K(-20.0%)
Jun 1996
-
$500.00K(0.0%)
Mar 1996
-
$500.00K(-28.6%)
Dec 1995
$700.00K(-12.5%)
$700.00K(+16.7%)
Sep 1995
-
$600.00K(-25.0%)
Jun 1995
-
$800.00K(0.0%)
Mar 1995
-
$800.00K(0.0%)
Dec 1994
$800.00K
$800.00K(-20.0%)
Sep 1994
-
$1.00M(0.0%)
Jun 1994
-
$1.00M(-9.1%)
Mar 1994
-
$1.10M

FAQ

  • What is BioCryst Pharmaceuticals annual total long term liabilities?
  • What is the all time high annual long term liabilities for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals annual long term liabilities year-on-year change?
  • What is BioCryst Pharmaceuticals quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for BioCryst Pharmaceuticals?
  • What is BioCryst Pharmaceuticals quarterly long term liabilities year-on-year change?

What is BioCryst Pharmaceuticals annual total long term liabilities?

The current annual long term liabilities of BCRX is $805.97M

What is the all time high annual long term liabilities for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high annual total long term liabilities is $822.50M

What is BioCryst Pharmaceuticals annual long term liabilities year-on-year change?

Over the past year, BCRX annual total long term liabilities has changed by -$16.53M (-2.01%)

What is BioCryst Pharmaceuticals quarterly total long term liabilities?

The current quarterly long term liabilities of BCRX is $792.12M

What is the all time high quarterly long term liabilities for BioCryst Pharmaceuticals?

BioCryst Pharmaceuticals all-time high quarterly total long term liabilities is $843.15M

What is BioCryst Pharmaceuticals quarterly long term liabilities year-on-year change?

Over the past year, BCRX quarterly total long term liabilities has changed by -$32.02M (-3.89%)
On this page